Skip to main content
Paul F. Bray, MD, Hematology, Salt Lake City, UT

Paul F.BrayMD

Hematology • Salt Lake City, UT

Professor, Medicine, Jefferson Medical College-Thos Jefferson Univ

Join to view full profile

Dr. Bray is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bray's full profile

Already have an account?

  • Office

    1950 Circle of Hope Dr
    Salt Lake City, UT 84112
    Phone+1 801-581-8793

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1982 - 1985
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1977 - 1980
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 1977

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Abstracts/Posters

  • The Mir-99b/Let-7e/Mir-125a cluster Is Associated with Platelet Count and Mean Platelet Volume and Regulates Megakaryocyte Proplatelet Formation
    Paul F. Bray, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Grant Support

  • MicroRNA function in human megakaryocytesNational Institutes of Health2014–Present
  • Variation In Platelet Function: The Genetics Of Platelet Gene ExpressionNational Heart, Lung, And Blood Institute2010–2012
  • Identifying Genes Regulating Platelet ReactivityNational Heart, Lung, And Blood Institute2007–2011
  • Postmenopause CHD RISK: Platelet Genes &Hormone TherapyNational Heart, Lung, And Blood Institute2006
  • Platelet, Shear Stress, And Arterial ThrombosisNational Heart, Lung, And Blood Institute2005
  • Basic And Clinical Research Training In ThrombosisNational Heart, Lung, And Blood Institute2004–2005
  • Postmenopause CHD RISK: Platelet Genes &Hormone TherapyNational Heart, Lung, And Blood Institute2003–2005
  • Genetic Basis Of Platelet HyperfunctionNational Heart, Lung, And Blood Institute2000–2004
  • Genetic Variations Affecting GP Ib-Ix/Iib-Iiia AxisNational Heart, Lung, And Blood Institute2001–2002
  • Platelet P1a2--Studies On A PRO Thrombotic PolymorphismNational Heart, Lung, And Blood Institute2000–2001
  • Mechanisms Of Arterial Thrombosis In WomenNational Heart, Lung, And Blood Institute1999
  • Platelet P1a2--Studies On A PRO Thrombotic PolymorphismNational Heart, Lung, And Blood Institute1997–1999
  • Mechanisms Of Arterial Thrombosis In WomenNational Heart, Lung, And Blood Institute1997–1999
  • In Vitro And Ex Vivo Studies On MegakaryocytopoiesisNational Heart, Lung, And Blood Institute1994–1997
  • Cellular Consequences Of Defective IIB And IIIA GenesNational Heart, Lung, And Blood Institute1990–1993
  • Biosynthesis NAD Structure Of The Fibrinogen ReceptorNational Heart, Lung, And Blood Institute1990
  • Cellular Consequences Of Defective IIB And IIIA GenesNational Heart, Lung, And Blood Institute1989
  • Biosynthesis NAD Structure Of The Fibrinogen ReceptorNational Heart, Lung, And Blood Institute1986–1989

Dr. Paul F. Bray, Dr. Paul F. Bray, MD, Dr. P Bray